Hypoxia influences stem cell-like properties in multidrug resistant K562 leukemic cells, Blood Cells Mol Dis, vol.51, pp.177-84, 2013. ,
HIF-1?-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia, Pharmacol Res Off J Ital Pharmacol Soc, vol.62, pp.416-441, 2010. ,
Pronounced hypoxia in models of murine and human leukemia: high efficacy of hypoxia-activated prodrug PR-104, PLoS One, vol.6, 2011. ,
HIF-2? protects human hematopoietic stem/ progenitors and acute myeloid leukemic cells from apoptosis induced by endoplasmic reticulum stress, Cell Stem Cell, vol.13, pp.549-63, 2013. ,
Targeting hypoxia in cancer therapy, Nat Rev Cancer, vol.11, pp.393-410, 2011. ,
Initial testing of the hypoxia-activated prodrug PR-104 by the pediatric preclinical testing program, Pediatr Blood Cancer, vol.57, pp.443-53, 2011. ,
Regulation of HIF-1? signaling and chemoresistance in acute lymphocytic leukemia under hypoxic conditions of the bone marrow microenvironment, Cancer Biol Ther, vol.13, pp.858-70, 2012. ,
Regulation of metabolism by hypoxia-inducible factor 1, Cold Spring Harb Symp Quant Biol, vol.76, pp.347-53, 2011. ,
HIF1? and HIF2?: sibling rivalry in hypoxic tumour growth and progression, Nat Rev Cancer, vol.12, pp.9-22, 2012. ,
Acute lymphoblastic leukemia in adolescents and young adults, Hematol Oncol Clin North Am, vol.23, pp.1033-1075, 2009. ,
Immunophenotypic cell lineage and in vitro cellular drug resistance in childhood relapsed acute lymphoblastic leukaemia, Eur J Cancer Oxf Engl, vol.41, pp.1300-1303, 2005. ,
Relapse of acute lymphoblastic leukemia in children in the context of microarray analyses, Arch Immunol Ther Exp, vol.59, pp.61-69, 2011. ,
Association of high-level MCL-1 expression with in vitro and in vivo prednisone resistance in MLL-rearranged infant acute lymphoblastic leukemia, Blood, vol.115, pp.1018-1043, 2010. ,
Gene expression-based chemical genomics identifies rapamycin as a modulator of MCL1 and glucocorticoid resistance, Cancer Cell, vol.10, pp.331-373, 2006. ,
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment, N Engl J Med, vol.351, pp.533-575, 2004. ,
PKR negatively regulates leukemia progression in association with PP2A activation, Bcl-2 inhibition and increased apoptosis, Blood Cancer J, vol.3, p.144, 2013. ,
Reversal of multidrug resistance by 5,5?-dimethoxylariciresinol-4-O-?-D-glucoside in doxorubicin-resistant human leukemia K562/DOX, Indian J Pharmacol, vol.45, pp.597-602, 2013. ,
Reverse-phase protein array analysis to identify biomarker proteins in human pancreatic cancer, Dig Dis Sci, vol.59, pp.968-75, 2014. ,
Changes in signaling pathways induced by vandetanib in a human medullary thyroid carcinoma model, as analyzed by reverse phase protein array, Thyroid Off J Am Thyroid Assoc, vol.24, pp.43-51, 2014. ,
Direct injection liquid chromatography/positive ion electrospray ionization mass spectrometric quantification of methotrexate, folinic acid, folic acid and ondansetron in human serum, J Chromatogr B Analyt Technol Biomed Life Sci, vol.877, pp.3850-3856, 2009. ,
Intracellular disposition of methotrexate in acute lymphoblastic leukemia in children, Curr Drug Metab, vol.13, pp.822-856, 2012. ,
New antifolates: pharmacology and clinical applications, Oncologist, vol.1, pp.68-81, 1996. ,
Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs, Blood, vol.92, pp.259-66, 1998. ,
EMP1, a novel poor prognostic factor in pediatric leukemia regulates prednisolone resistance, cell proliferation, migration and adhesion, Leukemia, vol.28, pp.1828-1865, 2014. ,
Infrared-based protein detection arrays for quantitative proteomics, Proteomics, vol.7, pp.558-64, 2007. ,
Measurement of protein using bicinchoninic acid, Anal Biochem, vol.150, pp.76-85, 1985. ,
Vincristine and prednisolone combination reduces MDR1 and microenvironment-mediated treatment resistance in acute lymphoblastic leukemia, Blood, vol.122, p.2529, 2013. ,
Divergent mechanisms of glucocorticoid resistance in experimental models of pediatric acute lymphoblastic leukemia, Cancer Res, vol.67, pp.4482-90, 2007. ,
In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia, Blood, vol.86, pp.3861-3869, 1995. ,
The synergism of MCL1 and glycolysis on pediatric acute lymphoblastic leukemia cell survival and prednisolone resistance, Haematologica, vol.98, pp.1905-1916, 2013. ,
XIAP and P-glycoprotein co-expression is related to imatinib resistance in chronic myeloid leukemia cells, Leuk Res, vol.37, pp.1350-1358, 2013. ,
Prolonged survival of B-lineage acute lymphoblastic leukemia cells is accompanied by overexpression of bcl-2 protein, Blood, vol.81, pp.1025-1056, 1993. ,
Comparative proteomics analysis of differential proteins in respond to doxorubicin resistance in myelogenous leukemia cell lines, Proteome Sci, vol.13, p.1, 2015. ,
Regulation of calcium signaling in lung cancer, J Thorac Dis, vol.2, pp.52-58, 2010. ,
Caspase-resistant vimentin suppresses apoptosis after photodynamic treatment with a silicon phthalocyanine in jurkat cells, Arch Biochem Biophys, vol.390, pp.57-63, 2001. ,
Reversal effect of bufalin on multidrug resistance in K562/VCR vincristine-resistant leukemia cell line, J Tradit Chin Med Chung Tsa Chih Ying Wen Pan Spons -China Assoc Tradit Chin Med Acad Tradit Chin Med, vol.34, pp.678-83, 2014. ,
Bone marrow stromal-derived soluble factors and direct cell contact contribute to de novo drug resistance of myeloma cells by distinct mechanisms, Leukemia, vol.17, pp.1175-82, 2003. ,
Mesenchymal cells regulate the response of acute lymphoblastic leukemia cells to asparaginase, J Clin Invest, vol.117, pp.1049-57, 2007. ,
Cytokines, growth, and environment factors in bone marrow plasma of acute lymphoblastic leukemia pediatric patients, Eur Cytokine Netw, vol.25, pp.8-13, 2014. ,
Interaction between leukemic-cell VLA-4 and stromal fibronectin is a decisive factor for minimal residual disease of acute myelogenous leukemia, Nat Med, vol.9, pp.1158-65, 2003. ,
Hypoxia mediates low cell-cycle activity and increases the proportion of long-term-reconstituting hematopoietic stem cells during in vitro culture, Exp Hematol, vol.38, pp.301-311, 2010. ,
Regulation of the HIF-1alpha level is essential for hematopoietic stem cells, Cell Stem Cell, vol.7, pp.391-402, 2010. ,
The role of oxygen availability in embryonic development and stem cell function, Nat Rev Mol Cell Biol, vol.9, pp.285-96, 2008. ,
Deregulation of apoptosis in acute myeloid leukemia, Haematologica, vol.92, pp.81-94, 2007. ,
Down-regulation of mcl-1 by small interfering RNA sensitizes resistant melanoma cells to fas-mediated apoptosis, Mol Cancer Res MCR, vol.6, pp.42-52, 2008. ,
URL : https://hal.archives-ouvertes.fr/hal-00255012
X-linked inhibitor of apoptosis protein -a critical death resistance regulator and therapeutic target for personalized cancer therapy, Front Oncol, vol.4, p.197, 2014. ,
Expression and prognostic significance of IAP-family genes in human cancers and myeloid leukemias, Clin Cancer Res Off J Am Assoc Cancer Res, vol.6, pp.1796-803, 2000. ,
Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms, J Biol Chem, vol.276, pp.18702-18711, 2001. ,
Induction of vascular endothelial growth factor and hypoxia-inducible factore-1alpha by global ischemia in rat brain, Neurosc, vol.99, pp.577-85, 2000. ,